Abbott Laboratory Signs Agreement with Enfer Scientific for Mad Cow Disease Tests

Article

ABBOTT PARK, Ill-Abbott Laboratories announced that it has agreed to work with Enfer Scientific Ltd. for the marketing and distribution of two diagnostic tests used to detect bovine spongiform encephalopathy (BSE) in cattle.

The tests, developed by Enfer Scientific, are used to detect the presences of the abnormal prion protein associated with BSE, or Mad Cow disease. The first test is an ELISA (enzyme-linked immunosorbent assay) test, approved by the European Commission. The test has a rapid turnaround time.

The second test is a supplemental diagnostic test used to confirm positive results. Both are conducted on brain tissue and spinal cord samples from the cattle. Enfer Scientific, which is based in Tipperary, Ireland, will manufacture the tests, leaving Abbot to handle marketing under the Enfer name.

Bovine spongiform encephalopathy is a fatal neurological disease in cattle. The current theory is that Creutzfeldt-Jakob disease, a fatal neurological disease in humans, is a variant of BSE. Both are caused by prion proteins that assume the wrong shape and become lethal as they create plaques that are toxic to brain tissue.

For more information visit www.abbott.com.

Recent Videos
Anthony Bondon CRCST, CHL, BSM, AAS, SME, LSSYB
Deannard Esnard, CRCST, CIS, CER, CHL, CFER, CQUIA
Kevin Bush, Jr, DHSc, EdD, MSHA, MA, MS, FACHE
Vatsala Rangachar Srinivasa, MPH
Sarah Vinson, MBA, CRCST
Kevin Anderson, MBA, BS, CRCST, Senior Manager, Commercial Education Services, Heatlthmark, a Getinge Company
Damien Berg, BA, BS, CRCST, AAMIF, is the vice president of strategic initiatives for the HSPA.
Annet Adegboyega, DNP, MSN, BSN, RN, CNOR; Mihyun "Rose" Jang, MSN, MPH, BSN, RN, CNOR; and Renilda Tijones, MSN, BSN, RN, CNOR.
Roundtable of Vet IPs (Adobe Stock)
APIC 2025 President Carol McLay, DrPH, MPH, RN, CIC FAPIC   (Image credit: APIC)
Related Content